BSECompany Update2 Nov 2026 · 2 Nov 2026, 05:03 pm
Non - Applicability of Statement of Deviation or Variation in Utilisation of Funds under Regulation 32 of SEBI (LODR) Regualtions, 2015.
Symbiox Investment & Trading Company Ltd · 539278
✦ AI Summary
Symbiox Investment & Trading Company Ltd has confirmed that it did not raise any funds through public issue, rights issue, or preferential issue during the quarter ended September 30, 2026, and therefore, the statement of deviation or variation in utilization of funds under Regulation 32 of SEBI (LODR) Regulations, 2015 is not applicable to the company.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Symbiox Investment & Trading Company Ltd - 539278 - Non - Applicability Of Statement Of Deviation Or Variation In Utilisation Of Funds Under Regulation 32 Of SEBI (LODR) Regulations, 2015.
Attachments (1)
📄pdf
Download →
0163319f-62c0-4824-bc92-772cde2f7756.pdf
View document text
Syymmbiboxi ox Investmen&t Tradii ng Co. Ltd. 2o21, R abind ora LSarani, 3 trdFl
Contact: 98302 74227
CIN : L65993WB1979PLC032012
Website : www.symbioxinvestment.com
E-mail : symbioxinvestment100@gmail.com
Date: 2" November, 2026
To, To,
Compliance Department The Calcutta Stock Exchange Limited
Metropolitan Stock Exchange of India Limited 7 Lyons Range,
Vibgyor Towers, 4th floor, Plot No C 62, G - Block, Kolkata —700 001
Opp. Trident Hotel, Bandra Kurla Complex,
Bandra (E),
Mumbai — 400 098
The Bombay Stock Exchange Limited
Corporate Relationship Dept,
Phiroze Jegjeebhoy Towers
Dalal Street
Mumbai- 400001
Sub: Statement of Deviation or Variation in Utilisation of Funds under Regulation 32 of SEBI
(Listing Obligations and Disclosure Requirements) Regulations, 2015,
Ref. Script Code:- BSE-539278; MSEI- SYMBIOX: CSE- 029461
Dear Sir/ Madam,
Pursuant to the Regulation 32 of the Securities and Exchange Board of India (Listing Obligations
and Disclosure Requirements) Regulations, 2015, the Company hereby confirms, that Company has
not raised any funds through Public Issue, Rights Issue, Preferential Issue, QIP etc. during the quarter
ended 30™ September, 2026.
Hence. the statement of Deviation or variation in Public Issue, Rights Issue, Preferential issue, etc under
Regulation 32 of SEBI (Listing Obligations Disclosure Requirements) Regulations, 2015 for the
quarter ended 30" September, 2026 is not applicable to the Company.
This is for your kind perusal and please acknowledge the same.
Thanking You.
Yours faithfully
For, Symbiox Investment & Lrading Co. Ltd,
Company Secretary & Conipliance Officer
Membership No. A25950